Cramer's lightning round: Hold, don't buy, this drugmaker over its patent cliff
May 12, 2017 at 18:46 PM EDT
Jim Cramer flies through his take on caller favorite stocks, including this pharma play.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.